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ABSTRACT 
Objective: Simple, sensitive, precise, reproducible and validated spectrophotometric methods have been developed for the quantification of 
montelukast sodium as leukotriene receptor antagonist drug, in pure and dosage forms (tablets).  
Methods: The methods use N-bromosuccinimide (NBS) as an oxidant and three dyes, amaranth, methylene blue, and indigo carmine, as auxiliary 
reagents. The three methods are based on oxidation reaction of montelukast sodium with a known excess of N-bromosuccinimide (NBS) in acid 
medium, followed by determination of unreacted NBS by the reaction with a fixed amount of dyes, amaranth, methylene blue, and indigo carmine 
followed by the measurement of the absorbance at 520, 664 and 610 nm, respectively.  
Results: Under the optimum conditions, linear relationships with good correlation coefficients (0.9993-0.9996) were found over the concentration 
ranges of 0.5-10, 1.0-12 and 0.5-8.0 µg/ml with a limit of detection (LOD) of 0.15, 0.3 and 0.14 µg/ml using amaranth, methylene blue, and indigo 
carmine methods, respectively. Intra-day and inter-day accuracy and precision of the methods have been evaluated. No interference was observed 
from the common tablet excipients.  
Conclusion: The proposed methods were validated in accordance with ICH guidelines and successfully applied to the analysis of montelukast 
sodium in dosage forms (tablets). The reliability of the methods was further ascertained by performing recovery studies using the standard addition 
method. Statistical comparison of the results obtained by applying the proposed methods with those of the reported method by applying student’s t-
test and F-test revealed good agreement.  
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INTRODUCTION 
Montelukast sodium is chemically designated as [R-(E)]-1-[[[1-[3-[2-
(7-chloro-2quinolinyl) ethenyl] phenyl]-3-[2-(1-hydroxy-1-
methylethyl) phenyl] propyl]thio] methyl]cyclopropane acetic acid, 
sodium salt (MNT) (fig. 1) [1]. MNT is a leukotriene receptor 
antagonist used as an alternative to anti-inflammatory medications 





H3C CH3  
Fig. 1: The chemical structure of montelukast sodium (MNT) 
 
The literature survey revealed that few methods were described for 
the determination of MNT in pure, tablet dosage forms and 
biological fluids such as spectrofluorimetry [2], electrochemical [3], 
electrophoresis [4, 5] and high-performance liquid chromatography 
[6-13]. Most of these reported methods are either not appropriately 
sensitive or tedious and utilized expensive instruments that are not 
available in most quality control laboratories. 
In contrast, visible spectrophotometry is considered as the most 
convenient analytical technique in most quality control and clinical 
laboratories, hospitals and pharmaceutical industries for the assay 
of different classes of drugs in pure form, pharmaceutical 
formulations and biological samples, due to its simplicity, less 
expensive, less time consuming and reasonable sensitivity with 
significant economic advantages.  
To the best of our knowledge, there are some methods have been 
reported for the quantification of MNT in commercial dosage forms 
using a spectrophotometric technique using bromothymol blue and 
bromocresol purple [14], FeCl3 in HCl and orcinol in concentrated 
HCl [15], Wool fast blue [16], Fe3+
From the foregoing paragraphs, N-bromosuccinimide (NBS) despite 
its strong oxidizing power, versatility, and high oxidation potential 
and stability in solution has not been applied for the assay of MNT in 
pure forms and tablets.  
/1, 10-phenanthroline, MBTH and 
2, 2'-bipyridyl [17], UV-spectrophotometry [18-21]. However, these 
previously reported methods suffer from one or more disadvantage 
such as poor sensitivity, depending on critical experimental 
variables, few methods require a rigid pH control and tedious and 
time-consuming liquid–liquid extraction step; some other methods 
have a relatively narrow dynamic linear range, involve a heating 
step, and/or use of expensive reagent or large amounts of organic 
solvents. For these reasons, it was worthwhile to develop a new, 
simple, cost effective and selective spectrophotometric method for 
the determination of MNT their pharmaceutical dosage forms. 
The present investigation aims to develop for the first time simple, 
sensitive, accurate, precise and cost-effective spectrophotometric 
methods for the determination of MNT in pure and dosage forms. The 
proposed methods employ N-bromosuccinimide which acts as 
brominating agent, and dyes; amaranth (AM), methylene blue (MB) and 
indigo carmine (IC), as auxiliary chromogenic reagents. No interference 
was observed in the assay of MNT from common excipients in levels 
found in dosage forms. These methods are validated by statistical data. 
MATERIALS AND METHODS 
Apparatus 
All absorption spectra were made using Varian UV–Vis 
spectrophotometer (Cary 100 Conc., Australia) equipped with 10 
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mm quartz cell was used for absorbance measurements. This 
spectrophotometer has a wavelength accuracy of±0.2 nm with a 
scanning speed of 200 nm/min and a bandwidth of 2.0 nm in the 
wavelength range of 200–900 nm.  
Materials and reagents 
All chemicals, solvents and reagents used in this work were of analytical 
reagent or pharmaceutical grade and all solutions were prepared fresh 
daily. Bidistilled water was used throughout the investigation. 
Reference standard of pure MNT and pharmaceutical formulations 
Pure sample of MNT was kindly supplied by Delta Pharmaceutical 
Industries, Cairo, Egypt, with a purity of 99.70±0.52% by applying the 
reported method [14]. Montelair tablets, labeled to contain 5.0 mg MNT 
per tablet, product of Jedco Company, Cairo, Egypt. Delmonkast tablets, 
labeled to contain 10 mg MNT per tablet, product of 
Delta Pharmaceutical Industries, Cairo, Egypt were purchased from local 
pharmacies. 
Preparation of stock standard solution 
Stock standard solutions (100 µg/ml) and (1.0 × 10−3 mol /l) of MNT 
were prepared by dissolving 10 and 60.82 mg of pure MNT in bidistilled 
water and further diluted with bidistilled water to the mark in a 100 ml 
volumetric flask. The standard solutions were stable for at least 7.0 d 
when kept in the refrigerator. Serial dilution with the same solvent was 
performed to obtain the appropriate concentration range 
Reagents  
N-bromosuccinimide (NBS) (0.01 mol/l) 
A stock solution of 0.02 mol/l NBS (Sigma-Aldrish) was freshly 
prepared by dissolving about 0.356 g of NBS in least amount of 
warm bidistilled water in a 100 ml measuring flask and then diluted 
to the mark with bidistilled water and standardized [22]. The 
solution was kept in an amber colored bottle and was diluted 
appropriately to get 200 μg/ml NBS for use in all methods. The NBS 
solution was stored in a refrigerator when not in use.  
Potassium bromide (1.0% w/v) 
A 1.0% w/v KBr solution was also prepared by dissolving 1.0 g of 
KBr in 100 ml water.  
Hydrochloric acid (5.0 mol/l) 
A 5.0 mol/l of HCl was prepared by diluting 43 ml of concentrated 
acid (Merck, Darmstadt, Germany, Sp. gr. 1.18, 37%) to 100 ml with 
bidistilled water and standardized as recommended previously [23] 
prior to use.  
Dyes (1000 μg/ml) 
Stock solutions (1000 μg/ml) amaranth (AM), methylene blue (MB) 
and indigocarmine (IC) were first prepared by dissolving accurately 
weighed 112 mg of each dye (Sigma-aldrish, 90 % dye content) in 
bidistilled water and diluting to volume in a 100 ml calibrated flask. 
The solution was then diluted 5.0-fold to get the working 
concentration of 200 μg/ml of dyes.  
Recommended procedures 
Different aliquots (0.05-1.0 ml), (0.1-1.2 ml), and (0.05-0.8 ml) of a 
standard 100 μg/ml MNT solution using AM, MB and IC methods, 
respectively, were transferred into a series of 10 ml calibrated flasks 
by means of a micro burette. To each flask 1.5 ml each of 5.0 mol/l 
HCl; 2.0 ml of NBS solution (200 μg/ml) and 1.0 ml of 1.0% (w/v) 
KBr were added successively. The flasks were stoppered, content 
mixed, and the flasks were kept aside for 5.0 min with occasional 
shaking. Finally, 1.0 ml of (200 μg/ml) AM, MB and IC solution were 
added to each flask and mixed well, and then the volume was diluted 
to the mark with water. The absorbance of each solution was 
measured at 520, 664 and 610 nm for AM, MB and IC methods, 
respectively, after 3.0 min against a reagent blank. In all methods, a 
standard graph was prepared by plotting the absorbance versus the 
concentration of drug. The concentration of the unknown was read 
from the calibration graph or computed from the regression 
equation derived using Beer’s law data. 
Procedure for tablets 
The contents of twenty tablets of MNT were weighed accurately and 
ground into a fine powder. An accurate weight of the powdered 
tablets equivalent to 20 mg MNT was dissolved in bidistilled water 
in a 100 ml volumetric flask with shaking for 5.0 min and filtered 
using a Whatman No. 42 filter paper. The filtrate was diluted to the 
mark with bidistilled water in a 100 ml measuring flask to give 200 
μg/ml stock solution of VARD for analysis by spectrophotometric 
methods. A convenient aliquot was then subjected to analysis by the 
recommended procedures described above. Determine the nominal 
content of the tablets using the corresponding regression equation 
of the appropriate calibration graph. 
RESULTS AND DISCUSSION 
Absorption spectra 
Many dyes are irreversibly destroyed to colorless species by 
oxidizing agents in acid medium [24]. The proposed 
spectrophotometric methods are based on the reaction between 
MNT and measured excess of NBS and subsequent determination of 
the latter by reacting it with a fixed amount of AM, MB and IC dye, 
and measuring the absorbance at 520, 664 and 610 nm (fig. 2). 
These methods make use of the bleaching action of NBS on the dyes, 
the decolorization being caused by the oxidative destruction of the 
dyes. MNT when added in increasing concentrations to a fixed 
concentration of NBS consumes the latter and there will be a 
concomitant decrease in the concentration of NBS. When a fixed 
concentration of dye is added to decreasing concentrations of NBS, a 
concomitant increase in the concentration of dye is obtained. 
Consequently, a proportional increase in the absorbance at the 
respective λmax 
 
is observed with increasing concentrations of MNT. 
 
Fig. 2: Absorption spectra for the unreacted NBS that determined by reacting with a fixed amount of dyes and measuring the absorbance 
of unbleached dyes at 520, 664 and 610 nm for AM, MB and IC methods, respectively 
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Chemistry of the reactions 
NBS is a strong oxidizing or brominating agent and perhaps the most 
important positive bromine containing organic compound used for the 
determination of many pharmaceutical compounds [25-29]. It is also 
used for the specific purpose of brominating alkenes at the allylic 
position [30]. The analytical reactions involved two steps; the first one 
was concerned with the bromination of MNT with a known excess 
amount of NBS in hydrochloric acid medium. The second step involved 
the determination of the excess residual NBS via its reaction with a 
fixed amount of AM, MB and IC dyes and measuring the absorbance at 
the respective λmax
 
. The tentative reaction scheme of 
spectrophotometric methods is shown in Scheme 1. In all methods, the 
absorbance increased linearly with increasing concentration of MNT. 
The latter methods make use of the bleaching action of NBS on dyes, 
the discoloration being caused by the oxidative destruction of the dye. 
Known excess of NBS H
+
Reaction product of drug Unreacted NBSDrug  
Unreacted NBS




Unbleached color of MB measured at 664 nm
IC method
Unbleached color of IC measured at 610 nm  
Scheme 1: Tentative reaction scheme for the proposed spectrophotometric methods 
 
Selection of acid type and concentration 
The reaction between MNT and NBS was performed in different 
acid media HCl, H2SO 4, HNO 3, and CH3
 
-COOH solutions. Better 
results were suitable in hydrochloric acid medium. The effect of 
HCl concentration on the reaction between MNT and NBS was 
studied by varying the concentration of HCl keeping the 
concentrations of NBS and MNT fixed. The reaction was found to 
be rapid yielding a constant absorbance with maximum sensitivity 
and stability when the HCl concentration was 5.0 mol/l and 
maintained in the range of 0.25–3.0 ml of HCl (5.0 mol/l) in a total 
volume of 10 ml. The results indicated that, at 1.0-3.0 ml of HCl 
(5.0 mol/l), there were almost same absorbance values were 
obtained in the presence of MNT, the absorbance values obtained 
were constant and were almost the same as those of the reagent 
blank. At the acid volumes less than 1.0 ml, reaction led to go 
slower and incomplete. Therefore, 1.5 ml of HCl (5.0 mol/l) was 
used though out the study (fig. 3). 
 
Fig. 3: Effect of volume of HCl (5.0 mol/l) of the oxidation product of MNT with NBS and dyes 
 
 
Fig. 4: Effect of volume of NBS (200 μg/ml) of the oxidation product of MNT with NBS and dyes in HCl medium 
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Effect of NBS concentration 
To investigate the optimum concentration of NBS, different 
concentrations of NBS were treated in the range of 0.25–3.0 ml with 
a fixed concentration dyes in HCl medium and the absorbance was 
measured at optimum wavelength. It was found that maximum color 
intensity of the products was achieved with 2.0 ml of NBS (200 
μg/ml) (fig. 4). 
Effect of KBr concentration 
The effect of KBr concentration was studied in the range of 0.5–2.5 
ml. 1.0 ml of (1.0%, w/v) KBr was chosen as an optimum volume to 
accelerate the oxidation process. 
Effect of dye concentration 
The effect of AM, MB, and IC concentration on the intensity of the 
color developed was carried out to obtain the optimum 
concentration of dyes that produces the maximum and reproducible 
color intensity by reducing the residual of NBS. The effect dye 
concentration was studied in the range of 0.25–3.0 ml of each dye 
(200 μg/ml). It was found that maximum color intensity of the 
oxidation products was achieved with 1.5 ml AM, MB and IC solution, 
respectively (fig. 5). 
Effect of temperature and mixing time 
The effect of temperature was studied by heating a series of sample and 
blank solutions at different temperatures ranging from 25 to 60 °C in 
water bath. It was found that raising the temperature does not accelerate 
the oxidation process and does not give reproducible results, so 
maximum color intensity was obtained at room temperature (25±2 °C). 
The effect of mixing time required completing oxidation of MNT and for 
reducing the excess oxidant was studied by measuring the absorbance of 
sample solution against blank solution prepared similarly at various time 
intervals 2.0–20 min. It was found that the contact times gave constant 
and reproducible absorbance values at 5.0 min at room temperature 
(25±2 °C). The time required for complete oxidation of MNT is not 
critical and any delay up to 15 min in the determination of unreacted 
NBS had no effect on the absorbance. A 3.0 min standing time was found 
necessary for the complete bleaching of the dye color by the residual 
NBS was found necessary for complete reduction of residual NBS by all 




Fig. 5: Effect of volume of dyes (200 μg/ml) of the oxidation product of MNT with NBS and dyes in HCl medium 
 
Effect of sequence of addition 
The optimum sequence of the addition was MNT–HCl–NBS–KBr and 
then dye. Other sequences gave lower absorbance values under the 
same experimental conditions.  
Method validation  
The proposed methods have been validated for linearity, sensitivity, 
accuracy, precision, robustness, ruggedness and recovery. 
Linearity and sensitivity 
Under the optimum conditions, a linear correlation was found 
between absorbance at λmax
A = a+b C Eqn. 1 
 and the concentration of MNT in the 
ranges of 0.5-10, 1.0-12 and 0.5-8.0 μg/ml using AM, MB and IC, 
respectively (fig. 6). The calibration graph is described by the Eqn. 1.  
Where A= absorbance, a= intercept, b= slope and C= concentration 
in μg/ml, obtained by the method of least squares. Correlation 
coefficient, intercept and slope of the calibration data are 
summarized in table 1. For accurate determination, Ringbom 
concentration range [31] was calculated by plotting log 
concentration of drug in μg/ml against transmittance % from which 
the linear portion of the curve gives an accurate range of 
microdetermination of MNT and represented in table 1. Apparent 
molar absorptivity and Sandell’s sensitivity values were calculated 
and illustrated in table 1 as per the current ICH guidelines [32]. The 
high molar absorptivity and lower Sandell sensitivity values reflect 
the good and high sensitivity of the proposed methods. 
Sensitivity 
The limits of detection (LOD) and quantitation (LOQ) for the 
proposed methods were calculated using the following Eqn. 2. and 
Eqn. 3. [31, 32]:  
LOD = 3s/k Eqn. 2. 
LOQ = 10 s/k Eqn. 3. 
Where s is the standard deviation of ten replicate determinations 
values of the reagent blank and k is the sensitivity, namely the slope 
of the calibration graph. In accordance with the formula, the limit of 
detection was found to be 0.15, 0.30, and 0.14 μg/ml for AM, MB, and 
IC methods, respectively. According to this equation, the limit of 
quantitation was found to be 0.5, 1.0, and 0.47 μg/ml for AM, MB, 
and IC methods, respectively. 
The validity of the proposed methods was evaluated by statistical 
analysis [32] between the results achieved from the proposed 
methods and that of the reported method [14]. Regarding the 
calculated Student’s t-test and variance ratio F-test (table 1), there is 
no significant difference between the proposed and reported 
method [14] regarding accuracy and precision. 
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Fig. 6: Calibration curves for MNT using AM, MB and IC methods 
 
Table 1: Analytical and regression parameters of the proposed spectrophotometric methods for determination of MNT 
Parameters AM MB IC 
Beer’s law limits, μg/ml 0.5-10 1.0-12 0.5-8.0 
Ringboom limits, μg/ml 1.0-8.0 2.0-10 1.0-7.0 
Molar absorptivity, x 104 2.058  L/mol. cm 2.258 2.31 
Sandell sensitivity, ng/cm 29.55 2 26.93 26.32 
Regression equation  a   
Intercept (a) 0.0039 0.0059 0.0011 
Standard deviation of intercept (Sa 0.008 ) 0.009 0.006 
Slope (b) 0.0308 0.0341 0.037 
Standard deviation of slope (Sb 0.01 ) 0.014 0.009 
Correlation coefficient, (r) 0.9996 0.9993 0.9994 
mean±SD 99.89±1.50 99.62±1.60 100.63±1.04 
RSD% 1.50 1.61 1.03 
RE% 1.58 1.69 1.08 
Limit of detection, μg/ml 0.15 0.30 0.14 
Limit of quantification, μg/ml 0.50 1.0 0.47 
Calculated t-value 0.24 b 0.52 0.71 
Calculated F-value 1.33 b 1.51 1.56 
aA = a+bC, where C is the concentration in µg ml−1, A is the absorbance units, a is the intercept, b is the slope, b
 
The theoretical values of t and F are 
2.571 and 5.05, respectively at confidence limit at 95% confidence level and five degrees of freedom (p= 0.05).  
Table 2: Results of intra-day and inter-day accuracy and precision study for MNT obtained by the proposed methods 
















a RE % 
Confidence 
limit b 
AM 3.0 99.00 0.50 -1.0 2.97±0.016 100.50 0.60 0.50 3.015±0.019 
6.0 99.50 0.82 -0.50 5.97±0.051 99.20 0.96 -0.80 5.952±0.06 
9.0 99.80 1.30 -0.20 8.982±0.123 99.70 1.15 -0.30 8.973±0.108 
MB 4.0 99.30 0.60 -0.70 3.972±0.025 99.00 0.38 -1.0 3.96±0.016 
8.0 99.10 0.90 -0.90 7.928±0.075 99.70 0.75 -0.30 7.976±0.063 
12 100.50 1.50 0.50 12.06±0.19 98.80 1.10 -1.20 11.856±0.137 
IC 2.0 99.40 0.45 -0.60 1.988±0.009 99.20 0.55 -0.80 1.984±0.011 
4.0 100.70 0.83 0.70 4.028±0.035 99.30 0.80 -0.70 3.972±0.033 
6.0 98.70 1.80 -1.30 5.922±0.112 99.40 1.60 -0.60 5.964±0.1 
aRSD%, percentage relative standard deviation; RE%, percentage relative error, b
 
mean±standard error, confidence limit at 95% and five degrees of 
freedom (t = 2.571). 
Accuracy and precision 
In order to evaluate the precision of the proposed methods, 
solutions containing three different concentrations of MNT were 
prepared and analyzed in six replicates. The analytical results 
obtained from this investigation are summarized in table 2. Lower 
values of the relative standard deviation (RSD%) and percentage 
relative error (RE%) indicate the precision and accuracy of the 
proposed methods. The percentage relative error was calculated 
using the following equation (Eqn. 4.): 
𝐑𝐄% =  (𝐅𝐨𝐮𝐧𝐝−𝐀𝐝𝐝𝐞𝐝)
𝐀𝐝𝐝𝐞𝐝
 × 𝟏𝟎𝟎 Eqn. 4 
The assay procedure was repeated six times, and percentage relative 
standard deviation (RSD%) values were obtained within the same 
day to evaluate the repeatability (intra-day precision) and over five 
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different days to evaluate intermediate precision (inter-day 
precision). For the same concentrations of MNT inter-and intra-day 
accuracy of the methods was also evaluated. The percentage 
recovery values with respect to found concentrations of MNT were 
evaluated to ascertain the accuracy of the methods. These results of 
accuracy and precision show that the proposed methods have good 
repeatability and reproducibility. 
Robustness and ruggedness 
For the evaluation of method robustness, the volume of NBS was 
slightly altered (2.0±0.5 ml) and the reaction time (after adding 
NBS, time varied was 5.0±2.0 min) were slightly varied 
deliberately in the three methods. The analysis was performed 
with altered conditions by taking three different concentrations of 
MNT and the methods were found to remain unaffected as shown 
by the RSD values in the ranges of 0.78-2.50%. Methods 
ruggedness was expressed as the RSD of the same procedure 
applied by three different analysts as well as using three different 
instruments (spectrophotometers). The inter-analysts RSD were in 
the ranges 0.80-2.50%, whereas the inter-instruments RSD ranged 
from 0.70-2.30%, suggesting that the developed methods were 
rugged. The results are shown in table 3. 
 
Table 3: Results of method robustness and ruggedness (all values in RSD%) studies for MNT 






NBS volume Reaction time  Different analysts Different instruments  
AM 3.0 1.05 0.78 0.80 0.70 
 6.0 1.70 1.15 1.30 1.30 
 9.0 2.30 1.70 1.90 2.10 
MB 4.0 0.85 0.90 1.20 0.80 
 8.0 1.40 1.80 1.94 1.50 
 12 2.10 2.40 2.50 2.0 
IC 2.0 1.10 1.0 0.90 0.80 
 4.0 1.70 1.90 1.70 1.40 
 6.0 2.50 2.20 2.25 2.30 
aMean of three determinations, b
 
Volume of NBS is (2.0±0.5 ml) and reaction time is (5.0±2.0 min) were used 
Recovery studies 
To ascertain the accuracy, reliability and validity of the proposed 
methods, a recovery experiment was performed through standard 
addition technique. This study was performed by spiking three 
different levels of MNT (50, 100 and 150% of the level present in the 
tablet) to a fixed amount of MNT in tablet powder (pre-analyzed) 
and the total concentration was found by the proposed methods. The 
determination with each level was repeated three times and the 
percent recovery of the added standard was calculated from Eqn. 5. 
 [CF - CT] 
   Cp 
  
% Recovery  = x 100
 …. Eqn. 5 
Where CF is the total concentration of the analyte found, CT  is a 
concentration of the analyte present in the tablet preparation; CP
 
 is a 
concentration of analyte (pure drug) added to tablets preparations. 
The results of this study presented in table 4 revealed that the 
accuracy of the proposed methods was unaffected by the various 
excipients present in tablets, which did not interfere in the assay. 











Recoverya Added(μg/ml) (%) Recoverya(%) 
MontelairTablets 2.0 - 99.10 - 99.30 - 99.50  
 2.0 99.40 2.0 99.50 3.0 98.90  
 4.0 100.70 4.0 99.00 6.0 100.80  
 6.0 98.80 6.0 100.50 9.0 99.20  
mean±SD    99.50±0.84  99.00±0.65  99.53±0.93 99.63±0.59 
RSD%   0.84  0.64  0.93 0.59 
V   0.70  0.42  0.86 0.35 
S. E   0.42  0.33  0.46 0.26 
t-value  b  0.28  1.60  0.20  
F-value  b  2.03  1.21  2.48  
Delmonkast 
Tablets 
2.0 - 100.30 - 99.40 - 98.60  
 2.0 99.30 2.0 99.20 3.0 100.90  
 4.0 98.70 4.0 100.50 6.0 99.00  
 6.0 100.70 6.0 98.50 9.0 99.70  
mean±SD    99.75±0.91  99.40±0.83  99.55±1.01 99.50±0.68 
R. S. D%   0.91  0.83  1.01 0.68 
V   0.84  0.69  1.02 0.46 
S. E   0.46  0.41  0.50 0.30 
t-value  b  0.49  0.21  0.09  
F-value  b  1.79  1.49  2.21  
aAverage of six determinations, bTheoretical values of t and F are 2.571 and 5.05, respectively, at confidence limit at 95% confidence level and five 
degrees of freedom (p= 0.05). 
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Application of pharmaceutical formulations (tablets) 
The proposed methods were applied to the determination of MNT in 
tablets dosage forms. The results in table 4 showed that the methods 
are successful for the determination of MNT and that the excipients 
in the dosage forms do not interfere. A statistical comparison of the 
results obtained from the assay of MNT by the proposed methods 
and the reported method [14] for the same batch of material is 
presented in table 4. The results agree well with the label claim and 
also were in agreement with the results obtained by the reported 
method [14]. When the results were statistically compared with 
those of the reported method by applying the Student'
CONCLUSION 
s t-test for 
accuracy and F-test for precision, the calculated t-value and F-value 
at 95% confidence level did not exceed the tabulated values for five 
degrees of freedom [33]. Hence, no significant difference between 
the proposed methods and the reported method at the 95 % 
confidence level with respect to accuracy and precision. 
Three new, useful simple, rapid, and cost-effective 
spectrophotometric methods have been developed for the 
determination of MNT in pure and tablets dosage forms using NBS as 
a brominating agent and validated as per the current ICH guidelines. 
The present spectrophotometric methods are characterized by 
simplicity of operation, high selectivity, comparable sensitivity, low-
cost instrument, they do not involve any critical experimental 
variable and are free from tedious and time-consuming extraction 
steps and use of organic solvents unlike many of the previous 
methods reported for MNT. The assay methods have some 
additional advantages involve less stringent control of experimental 
parameters such as the stability of the colored system, accuracy, 
reproducibility, time of analysis, temperature independence and 
cheaper chemicals. These advantages encourage the application of 
the proposed methods in routine quality control analysis of MNT in 
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